\-\ Texto\\:\\ \ \(0\)\
\-\ essentially\\ normal\ \(17\)\
\-\ resection\ \(532\)\
\-\ on\\ t1w\\,\\ there\\ is\\ a\\ large\\ and\\ slightly\\ heterogeneous\\ high\\ signal\\ intensity\\ lesion\\ in\\ the\\ left\\ lateral\\ ventricle\\.\\ \\ this\\ lesion\\ is\\ dark\\ on\\ the\\ t2w\\ image\\ with\\ fat\\ suppression\\.\ \(0\)\
\-\ liponeurocytoma\ \(0\)\
\-\ \\â\\€\\¢\\ choroid\\ plexus\\ neoplasm\\ \\(papilloma\\ or\\ carcinoma\\)\ \(0\)\
\-\ \\â\\€\\¢\\ ependymoma\\ \\(with\\ lipoblastic\\ differentiation\\)\ \(0\)\
\-\ \\â\\€\\¢\\ choroid\\ plexus\\ lipoma\ \(0\)\
\-\ \\â\\€\\¢\\ meningioma\\ with\\ fat\\ \\(\\"lipoblastic\\ meningioma\\"\\)\ \(0\)\
\-\ \\â\\€\\¢\\ liponeurocytoma\ \(0\)\
\-\ \\â\\€\\¢\\ xanthogranuloma\\ of\\ the\\ choroid\\ plexus\ \(0\)\
\-\ 75\\ y\\.o\\.\\ man\\ with\\ headaches\ \(1\)\
\-\ this\\ patient\\ is\\ rather\\ old\\ for\\ a\\ primary\\ choroid\\ plexus\\ neoplasm\\.\\ \\ both\\ benign\\ choroid\\ plexus\\ papilloma\\ \\(cpp\\)\\ and\\ malignant\\ choroid\\ plexus\\ carcinoma\\ \\(cpc\\)\\ usually\\ \\ present\\ under\\ the\\ age\\ of\\ five\\ \\(85\\%\\ \\<\\ 5\\ yrs\\)\\.\\ \\ neurocytoma\\ usually\\ presents\\ in\\ middle\\ age\\ \\(mean\\ of\\ 50yrs\\)\\.\\ \\ meningioma\\ and\\ xanthogranuloma\\ present\\ in\\ older\\ patients\\;\\ and\\,\\ choroid\\ metastasis\\ present\\ in\\ older\\ patients\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ choroid\\:\\ 0\\.20084340719730875\ \(0\)\
\-\ plexus\\:\\ 0\\.16389786828372754\ \(0\)\
\-\ lipoblastic\\:\\ 0\\.11599366347324339\ \(0\)\
\-\ liponeurocytoma\\:\\ 0\\.10687330583429674\ \(0\)\
\-\ xanthogranuloma\\:\\ 0\\.09775294819535009\ \(0\)\
\-\ meningioma\\:\\ 0\\.06485702637740279\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.06185582966825873\ \(0\)\
\-\ 50yrs\\:\\ 0\\.05799683173662169\ \(0\)\
\-\ older\\:\\ 0\\.05664024891381116\ \(0\)\
\-\ papilloma\\:\\ 0\\.056496445354177076\ \(0\)\
\-\ cpc\\:\\ 0\\.05343665291714837\ \(0\)\
\-\ cpp\\:\\ 0\\.048876474097675045\ \(0\)\
\-\ neoplasm\\:\\ 0\\.038291533893578\ \(0\)\
\-\ suppression\\:\\ 0\\.03828806677902965\ \(0\)\
\-\ present\\:\\ 0\\.038092278038125274\ \(0\)\
\-\ yrs\\:\\ 0\\.035620533173054886\ \(0\)\
\-\ neurocytoma\\:\\ 0\\.035620533173054886\ \(0\)\
\-\ mean\\:\\ 0\\.03499349251644748\ \(0\)\
\-\ age\\:\\ 0\\.034222504283477714\ \(0\)\
\-\ fat\\:\\ 0\\.03419621477475833\ \(0\)\
\-\ usually\\:\\ 0\\.0341437928140363\ \(0\)\
\-\ \\(\\:\\ 0\\.033266658445440946\ \(0\)\
\-\ \\)\\:\\ 0\\.032860288452586414\ \(0\)\
\-\ t1w\\:\\ 0\\.032259838279857574\ \(0\)\
\-\ carcinoma\\:\\ 0\\.031867469342314034\ \(0\)\
\-\ essentially\\:\\ 0\\.03151425482389045\ \(0\)\
\-\ t2w\\:\\ 0\\.03151425482389045\ \(0\)\
\-\ 85\\:\\ 0\\.03139781023771018\ \(0\)\
\-\ dark\\:\\ 0\\.030739366431414245\ \(0\)\
\-\ differentiation\\:\\ 0\\.02995288517713936\ \(0\)\
\-\ patients\\:\\ 0\\.029099665781131916\ \(0\)\
\-\ 75\\:\\ 0\\.028768862943922245\ \(0\)\
\-\ five\\:\\ 0\\.028037115344512878\ \(0\)\
\-\ rather\\:\\ 0\\.02672321205829035\ \(0\)\
\-\ lipoma\\:\\ 0\\.02628445301553593\ \(0\)\
\-\ ependymoma\\:\\ 0\\.025165038402551063\ \(0\)\
\-\ under\\:\\ 0\\.024566539861723913\ \(0\)\
\-\ lesion\\:\\ 0\\.022902042447374402\ \(0\)\
\-\ slightly\\:\\ 0\\.022725172751691267\ \(0\)\
\-\ \\<\\:\\ 0\\.021697799523038096\ \(0\)\
\-\ headaches\\:\\ 0\\.021489752230732094\ \(0\)\
\-\ ventricle\\:\\ 0\\.021068357352489655\ \(0\)\
\-\ metastasis\\:\\ 0\\.02104439030460478\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.020672336557861878\ \(0\)\
\-\ middle\\:\\ 0\\.020560256379226562\ \(0\)\
\-\ intensity\\:\\ 0\\.020320201818284873\ \(0\)\
\-\ malignant\\:\\ 0\\.020320201818284873\ \(0\)\
\-\ benign\\:\\ 0\\.019401647151534217\ \(0\)\
\-\ image\\:\\ 0\\.017560455041431583\ \(0\)\
\-\ resection\\:\\ 0\\.017532339838948807\ \(0\)\
\-\ primary\\:\\ 0\\.01665384383484011\ \(0\)\
\-\ 5\\:\\ 0\\.016448423831869494\ \(0\)\
\-\ y\\.o\\:\\ 0\\.01622618047754408\ \(0\)\
\-\ high\\:\\ 0\\.015385171454452734\ \(0\)\
\-\ signal\\:\\ 0\\.014822857436005123\ \(0\)\
\-\ both\\:\\ 0\\.014356578886092902\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.013816677879156691\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.01355098356567265\ \(0\)\
\-\ \\;\\:\\ 0\\.01332513939771443\ \(0\)\
\-\ man\\:\\ 0\\.013295604230855258\ \(0\)\
\-\ \\%\\:\\ 0\\.01311395416675005\ \(0\)\
\-\ this\\:\\ 0\\.012646542280449119\ \(0\)\
\-\ large\\:\\ 0\\.012293042314678156\ \(0\)\
\-\ lateral\\:\\ 0\\.012149131879108883\ \(0\)\
\-\ presents\\:\\ 0\\.01148450194413109\ \(0\)\
\-\ is\\:\\ 0\\.011097844310224847\ \(0\)\
\-\ in\\:\\ 0\\.011089400793164603\ \(0\)\
\-\ on\\:\\ 0\\.009524881741650369\ \(0\)\
\-\ normal\\:\\ 0\\.008813239832888823\ \(0\)\
\-\ there\\:\\ 0\\.008366549713585452\ \(0\)\
\-\ or\\:\\ 0\\.0065889654537086015\ \(0\)\
\-\ left\\:\\ 0\\.006290166245216544\ \(0\)\
\-\ old\\:\\ 0\\.005756148663567464\ \(0\)\
\-\ patient\\:\\ 0\\.005635473229713079\ \(0\)\
\-\ a\\:\\ 0\\.005218418444981596\ \(0\)\
\-\ for\\:\\ 0\\.004796764135807336\ \(0\)\
\-\ and\\:\\ 0\\.0047370790982162745\ \(0\)\
\-\ the\\:\\ 0\\.003638139071148047\ \(0\)\
\-\ \\,\\:\\ 0\\.003561974546280097\ \(0\)\
\-\ with\\:\\ 0\\.003079057265523414\ \(0\)\
\-\ of\\:\\ 0\\.0022994171210129295\ \(0\)\
\-\ \\.\\:\\ 0\\.001634847057114631\ \(0\)\
